Benjamin R. Tan, Jr., M.D.

Publications

• Wang-Gillam A, Plambeck-Suess S, Goedegebuure P, Simon PO, Mitchem JB, Hornick JR, Sorscher S, Picus J, Suresh R, Lockhart AC, Tan B, Hawkins WG
  A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma.
  Invest New Drugs 2013 Jun;31(3):707-13
• Peddi PF, Lubner S, McWilliams R, Tan BR, Picus J, Sorscher SM, Suresh R, Lockhart AC, Wang J, Menias C, Gao F, Linehan D, Wang-Gillam A
  Multi-institutional experience with FOLFIRINOX in pancreatic adenocarcinoma.
  JOP 2012 Sep 10;13(5):497-501
• Fajardo AD, Tan B, Reddy R, Fleshman J
  Delayed repeated intraperitoneal chemotherapy after cytoreductive surgery for colorectal and appendiceal carcinomatosis.
  Dis Colon Rectum 2012 Oct;55(10):1044-52
• Thomas F, Motsinger-Reif AA, Hoskins JM, Dvorak A, Roy S, Alyasiri A, Myerson RJ, Fleshman JW, Tan BR, McLeod HL
  Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer.
  Br J Cancer 2011 Nov 22;105(11):1654-62
• Fracasso PM, Williams KJ, Chen RC, Picus J, Ma CX, Ellis MJ, Tan BR, Pluard TJ, Adkins DR, Naughton MJ, Rader JS, Arquette MA, Fleshman JW, Creekmore AN, Goodner SA, Wright LP, Guo Z, Ryan CE, Tao Y, Soares EM, Cai SR, Lin L, Dancey J, Rudek MA, McLeod HL, Piwnica-Worms H
  A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.
  Cancer Chemother Pharmacol 2011 Jun;67(6):1225-37
• Tan BR, Thomas F, Myerson RJ, Zehnbauer B, Trinkaus K, Malyapa RS, Mutch MG, Abbey EE, Alyasiry A, Fleshman JW, McLeod HL
  Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma.
  J Clin Oncol 2011 Mar 1;29(7):875-83
• Mamon HJ, Niedzwiecki D, Hollis D, Tan BR, Mayer RJ, Tepper JE, Goldberg RM, Blackstock AW, Fuchs CS
  A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma: Cancer and Leukemia Group B (CALGB) 80003.
  Cancer 2011 Jun 15;117(12):2620-8
• Thomas F, Hoskins JM, Dvorak A, Tan BR, McLeod HL
  Detection of the G>C SNP and rare mutations in the 28-bp repeat of TYMS using gel-based capillary electrophoresis.
  Pharmacogenomics 2010 Dec;11(12):1751-1756
• Wildes TM, Kallogjeri D, Powers B, Vlahiotis A, Mutch M, Spitznagel EL, Tan B, Piccirillo JF
  The benefit of adjuvant chemotherapy in elderly patients with stage III colorectal cancer is independent of age and comorbidity.
  J Geriatr Oncol 2010 Oct 1;1(2):48-56
• Williams KJ, Picus J, Trinkhaus K, Fournier CC, Suresh R, James JS, Tan BR
  Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study.
  HPB (Oxford) 2010 Aug;12(6):418-26
• Morgensztern D, Baggstrom MQ, Pillot G, Tan B, Fracasso P, Suresh R, Wildi J, Govindan R
  A phase I study of pegylated liposomal doxorubicin and irinotecan in patients with solid tumors.
  Chemotherapy 2009;55(6):441-5
• Johnston FM, Tan MC, Tan BR Jr, Porembka MR, Brunt EM, Linehan DC, Simon PO Jr, Plambeck-Suess S, Eberlein TJ, Hellstrom KE, Hellstrom I, Hawkins WG, Goedegebuure P
  Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer.
  Clin Cancer Res 2009 Nov 1;15(21):6511-8
• Tan BR
  Colorectal and anal cancers.
  In: Cancer: Principles & Practice of Oncology Review, 2nd edition (Govindan R, ed), Lippincott Williams & Wilkins 2009
• Tan BR
  Small intestine and gastrointestinal stromal tumors.
  In: Cancer: Principles & Practice of Oncology Review, 2nd edition (Govindan R, ed), Lippincott Williams & Wilkins 2009
• Myerson RJ, Outlaw ED, Chang A, Birnbaum EH, Fleshman JW, Grigsby PW, Kodner IJ, Malayapa RS, Mutch MG, Parikh P, Picus J, Tan BR
  Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
  Int J Radiat Oncol Biol Phys 2009 Oct 1;75(2):428-35
• Fracasso PM, Picus J, Wildi JD, Goodner SA, Creekmore AN, Gao F, Govindan R, Ellis MJ, Tan BR, Linette GP, Fu CJ, Pentikis HS, Zumbrun SC, Egorin MJ, Bellet RE
  Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin, in resistant solid tumor malignancies.
  Cancer Chemother Pharmacol 2009 Feb;63(3):451-8
• Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, Blackstein ME, Blanke CD, von Mehren M, Brennan MF, Patel S, McCarter MD, Polikoff JA, Tan BR, Owzar K
  Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.
  Lancet 2009 Mar 28;373(9669):1097-104
• Stuart JE, Tan B, Myerson RJ, Garcia-Ramirez J, Goddu SM, Pilgram TK, Brown DB
  Salvage radioembolization of liver-dominant metastases with a resin-based microsphere: initial outcomes.
  J Vasc Interv Radiol 2008 Oct;19(10):1427-33
• Tan BR, Brenner WS, Picus J, Marsh S, Gao F, Fournier C, Fracasso PM, James J, Yen-Revollo JL, McLeod HL
  Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies.
  Ann Oncol 2008 Oct;19(10):1742-8
• Linehan DC, Tan MC, Strasberg SM, Drebin JA, Hawkins WG, Picus J, Myerson RJ, Malyapa RS, Hull M, Trinkaus K, Tan BR
  Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: a single-institution phase II study.
  Ann Surg 2008 Aug;248(2):145-51
• Tan BR, Carenza J, Picus J
  Treatment of locally advanced and metastatic pancreatic cancer.
  In: Contemporary Issues in Cancer Imaging (Reznik R, Husband JE, eds), Cambridge University, 2008:166-174
• Ratner L, Tan B
  HIV-associated malignancies.
  In: The Washington Manual of Oncology, Second Edition (Govindan R, Arquette M, eds), Lippincott Williams & Wilkins, 2008: 344-362
• Tan B, Picus J
  Gastrointestinal malignancies: colorectal malignancies.
  In: The Washington Manual of Oncology, Second Edition (Govindan R, Arquette M, eds), Lippincott Williams & Wilkins, 2008: 190-196
• Khambata-Ford S, Garrett CR, Meropol NJ, Basik M, Harbison CT, Wu S, Wong TW, Huang X, Takimoto CH, Godwin AK, Tan BR, Krishnamurthi SS, Burris HA 3rd, Poplin EA, Hidalgo M, Baselga J, Clark EA, Mauro DJ
  Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.
  J Clin Oncol 2007 Aug 1;25(22):3230-7
• Ho AS, Picus J, Darcy MD, Tan B, Gould JE, Pilgram TK, Brown DB
  Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.
  AJR Am J Roentgenol 2007 May;188(5):1201-7
• Cotter SE, Grigsby PW, Siegel BA, Dehdashti F, Malyapa RS, Fleshman JW, Birnbaum EH, Wang X, Abbey E, Tan B, Kodner IJ, Hunt SR, Lowney JK, Mutch MG, Dietz DW, Myerson RJ
  FDG-PET/CT in the evaluation of anal carcinoma.
  Int J Radiat Oncol Biol Phys 2006 Jul 1;65(3):720-5
• Alvarez G, Perry A, Tan BR, Wang HL
  Expression of epidermal growth factor receptor in squamous cell carcinomas of the anal canal is independent of gene amplification.
  Mod Pathol 2006 Jul;19(7):942-9
• Fracasso PM, Blum KA, Ma MK, Tan BR, Wright LP, Goodner SA, Fears CL, Hou W, Arquette MA, Picus J, Denes A, Mortimer JE, Ratner L, Ivy SP, McLeod HL
  Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar.
  Br J Cancer 2005 Jul 11;93(1):46-53
• Lin LL, Picus J, Drebin JA, Linehan DC, Solis J, Strasberg SM, Tan B, Thorstad WL, Myerson R
  A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma.
  Am J Clin Oncol 2005 Jun;28(3):234-41
• Tan B, Ratner L
  In: Cancer: Principles & Practice of Oncology Review, 1st edition (Govindan R, ed)
  Lippincott Williams & Wilkins 2005
• Tan BR, McLeod HL
  Pharmacogenetic influences on treatment response and toxicity in colorectal cancer.
  Semin Oncol 2005 Feb;32(1):113-9
• Akintola-Ogunremi O, Pfeifer JD, Tan BR, Yan Y, Zhu X, Hart J, Goldblum JR, Burgart L, Lauwers GY, Montgomery E, Lewin D, Washington K, Bronner M, Xiao SY, Greenson JK, Lamps L, Lazenby A, Wang HL
  Analysis of protein expression and gene mutation of c-kit in colorectal neuroendocrine carcinomas.
  Am J Surg Pathol 2003 Dec;27(12):1551-8
• Smukler AJ, Tan BR and Ratner L
  AIDS-related lymphomas.
  Contemporary Oncol 2003 Aug 15;2(12):1-11
• Fracasso PM, Rodriguez LC, Herzog TJ, Fears CL, Goodner SA, Govindan R, Picus J, Rader JS, Tan BR, Arquette MA
  Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies.
  Cancer 2003 Aug 1;98(3):610-7
• Blum K, Tan B
  Hematopoietic growth factors.
  In: The Washington Manual of Oncology (Govindan R, Arquette M, eds), Lippincott Williams & Wilkins, 2002
• Tan B, Picus J
  Pancreatic and hepatobiliary cancers.
  In: The Washington Manual of Oncology (Govindan R, Arquette M, eds), Lippincott Williams & Wilkins, 2002
• Tan B, Ratner L
  AIDS-associated malignancies.
  In: The Washington Manual of Oncology (Govindan R, Arquette M, eds), Lippincott Williams & Wilkins, 2002
• Fracasso PM, Rader JS, Govindan R, Herzog TJ, Arquette MA, Denes A, Mutch DG, Picus J, Tan BR, Fears CL, Goodner SA, Sun SL
  Phase I study of rubitecan and gemcitabine in patients with advanced malignancies.
  Ann Oncol 2002 Nov;13(11):1819-25
• Fracasso PM, Blum KA, Tan BR, Fears CL, Bartlett NL, Arquette MA, Clark RS
  Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies.
  Cancer 2002 Nov 15;95(10):2223-9
• Tan B, Picus J
  Chemotherapy for metastatic colorectal cancer: part II.
  Contemporary Oncol 2002 Aug 15;1(12):1-6
• Tan B, Picus J
  Chemotherapy for metastatic colorectal cancer: part I.
  Contemporary Oncol 2002 Aug 1;1(11):1-6
• Ratner L, Lee J, Tang S, Redden D, Hamzeh F, Herndier B, Scadden D, Kaplan L, Ambinder R, Levine A, Harrington W, Grochow L, Flexner C, Tan B, Straus D
  Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy.
  J Clin Oncol 2001 Apr 15;19(8):2171-8
• Tan B, Piwnica-Worms D, Ratner L
  Multidrug resistance transporters and modulation.
  Curr Opin Oncol 2000 Sep;12(5):450-8
• Tan BR, Bartlett NL
  Treatment advances in non-Hodgkin's lymphoma.
  Expert Opin Pharmacother 2000 Mar;1(3):451-66
• Fracasso PM, Tan BR Jr, Grieff M, Stephenson J Jr, Liapis H, Umbeck NL, Von Hoff DD, Rowinsky EK
  Membranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesothelioma.
  J Natl Cancer Inst 1999 Oct 20;91(20):1779-80
• Voulgaropoulou F, Tan B, Soares M, Hahn B, Ratner L
  Distinct human immunodeficiency virus strains in the bone marrow are associated with the development of thrombocytopenia.
  J Virol 1999 Apr;73(4):3497-504
• Tan B, Ratner L
  The use of new antiretroviral therapy in combination with chemotherapy.
  Curr Opin Oncol 1997 Sep;9(5):455-64